<DOC>
	<DOCNO>NCT01658514</DOCNO>
	<brief_summary>This study evaluate single dose delayed-release metformin ( Met DR ) behave subject normal kidney function , mild kidney dysfunction , moderate kidney dysfunction , severe kidney dysfunction . The safety tolerability Met DR also examine . In addition , study compare behavior single dose Met DR extended-release metformin ( Met XR ) placebo subject vary level kidney function described .</brief_summary>
	<brief_title>Assessing Behavior Met DR Subjects With Kidney Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . 18 80 ( inclusive ) year old Visit 1 ( Screening ) 2 . Male , female meet follow criterion : Not breastfeed Negative pregnancy test result Visit 1 ( Screening ) ( applicable postmenopausal surgically sterile female ) Surgically sterile , postmenopausal , childbearing potential , practice willing continue practice appropriate birth control entire duration study Body weight ≥45 kg 3 . Body mass index ( BMI ) 18.0 40.0 kg/m² ( inclusive ) Visit 1 ( Screening ) 4 . Had type 2 diabetes mellitus HbA1c ≤10.0 % 5 . Had physical examination clinically significant abnormality judge investigator 6 . Estimated glomerular filtration rate ( eGFR ) ≥15 mL/min/1.73 m² base Modification Diet Renal Disease ( MDRD ) equation 7 . Ability understand willingness adhere protocol requirement 1 . Had End Stage Renal Disease require dialysis severe renal dysfunction eGFR &lt; 15 mL/min/1.73 m² 2 . Was dialysis dialysis within 12 month Visit 1 ( Screening ) 3 . Had receive plan receive iodinate contrast dye within 1 week prior Visit 1 ( Screening ) study medication administration 4 . Was take take within 1 week Visit 1 cationic drug eliminate renal tubular secretion ( e.g. , amiloride , digoxin , morphine , procainamide , quinidine , quinine , ranitidine , triamterene , trimethoprim , vancomycin ) 5 . Had clinically significant medical condition could potentially affect study participation and/or personal wellbeing , judge investigator , include limited following condition : Hepatic disease Gastrointestinal disease Endocrine disorder ( type 2 diabetes mellitus allow ) Cardiovascular disease Central nervous system diseases Psychiatric neurological disorder Organ transplantation Chronic acute infection Orthostatic hypotension , faint spell blackouts Allergy hypersensitivity 6 . Had chronic disease require medication adjust past 14 day ( subject could take acute intermittent overthecounter medication Tylenol , need ) 7 . Had major surgery kind within 6 month Visit 1 ( Screening ) 8 . Had clinically significant find electrocardiogram ( ECG ) assess investigator Visit 1 ( Screening ) 9 . Had clinical laboratory test ( clinical chemistry , hematology , urinalysis ) abnormality , relate diabetes renal disease stable disease , judge investigator clinically significant Visit 1 ( Screening ) 10 . Had hemoglobin result &lt; 8 g/dL level indicate severe anemia renal origin 11 . Had physical , psychological , historical finding , investigator 's opinion , would make subject unsuitable study 12 . Had receive Byetta® shortacting insulin within 3 day Visit 1 ( Screening ) 13 . Had receive metformin within 4 week Visit 1 ( Screening ) 14 . Had drug treatment affect gastrointestinal motility gastric pH ( prescription overthecounter ) , include antacid medication Rolaids Pepcid , within 2 day Visit 2 15 . Abused drug alcohol history abuse investigator 's opinion would cause individual noncompliant study procedures 16 . Smoked 10 cigarette , 3 cigar , 3 pipe per day 17 . Had donate blood within 2 month Visit 1 ( Screening ) plan donate blood study 18 . Had receive investigational drug within one month ( seven halflives investigational drug , whichever great ) Visit 1 ( Screening ) 19 . Had know allergy hypersensitivity component study treatment 20 . Was employ Elcelyx Therapeutics , Inc ( employee , temporary contract worker , designee company )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>